Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization

Axillary Block Clinical Trial

— fLACON  

Official title:

Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03290404
• Other study ID #: 29BRC17.0072 fLACON
• Status: Completed
• First received: September 19, 2017
• Last updated: April 5, 2018
• Start date: November 13, 2017
• Est. completion date: March 19, 2018

Study information

• Verified date: November 2017
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Axillary block is the good anesthetic technique for upper limb surgery without exceeding a certain total dose injected of Local Anesthetic (AL).

The maximal recommended dose of Lidocaine adrenaline in the upper limb is 500 mg. The use of ultrasound helps guiding the locoregional anesthesia, and allows to decrease the AL concentration, thus decreasing the risks.

No previous study estimated a concentration of lidocaine lower than 1,5 % to realize upper limb surgery by axillary block.

The literature overestimating probably the rate of failure of the locoregional anesthesia under ultrasound-guidance, we suggest to estimate the rate of failure of the axillary block ultrasound-guided with the lidocaine 1 % adrenaline for realizing upper limb surgery in standard practice.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 292
• Est. completion date: March 19, 2018
• Est. primary completion date: March 19, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients operated for the upper limb under block axillaire

• Adult

• non-opposition

Exclusion Criteria:

• medical advice to realize axillary block

• medical advice to local anaesthetic

• Allergy

• Pregnant

• ASA 3 or more

Related Conditions & MeSH terms

• Axillary Block

Locations

Country	Name	City	State
France	CHRU de Brest	Brest
France	Hôpital Instruction des Armées	Brest
France	Centre Hospitalier Intercommunal de Cornouaille	Quimper

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Time of Block	Minutes	Day 1
Other	Total dose of Lidocaïne adrenaline used	mg	Day 1
Other	Patient satisfaction	questionnaire score	Day 1
Primary	Resort to an anesthesia for help in case of ineffectiveness of the block	Yes or no Yes or No	Day 1
Secondary	Block depth	Bromage score	Day 1